League of Legends World Championship is one of the biggest esports events of the year, and the 2025 edition lived up to the ...

Altimmune’s pemvidutide showed “class-leading signals” in non-invasive assessments and has “potentially best-in-class ...

Researchers highlight early diagnosis and tumour type differences as key factors improving outcomes in testicular cancer.

Q3 2025 Earnings Call Transcript November 11, 2025 Ceragon Networks Ltd. misses on earnings expectations. Reported EPS is ...

Grip strength was inversely associated with preclinical obesity progression, which was most pronounced from baseline to first dysfunction.

This paper introduces a novel AI-enhanced retirement planning platform that integrates behavioral economics principles with advanced machine learning techniques to optimize financial decision-making.

Global Motors is among the passenger car dealers also moving to tap into tax incentives to gain a pricing advantage in a ...

Most solar frames are produced with extruded aluminum and imported from Asia. Through this partnership, Nextracker will reshore critical manufacturing capacity and enable a domestic supply of ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that the first patient has been ...

Billions are being invested to revolutionize these American airports. Uncover the groundbreaking developments set to transform the way we fly.

DTC outcomes were comparable between immunocompromised patients, including those with HIV and ESRD, and immunocompetent patients.

Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 - WALTHAM, Mass., (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.